Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital

Wisconsin Medical Journal

Volumn 107, Issue 4, 2008, Pages 176-180

  Charipar, Ron ^a   Charipar, Elizabeth ^b  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EMERGENCY MEDICINE; EMERGENCY WARD; FEMALE; FUNCTIONAL STATUS; GENERAL PRACTICE; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NATIONAL INSITUTE OF NEUROLOGIC DISORDERS AND STROKE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; ORGANIZATION; PHYSICIAN; PRACTICE GUIDELINE; PROGNOSIS; RETROSPECTIVE STUDY; RURAL AREA; STATISTICAL ANALYSIS; SYMPTOM; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; UNITED STATES;

ACUTE DISEASE; AGED; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITALS, RURAL; HUMANS; MALE; RETROSPECTIVE STUDIES; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; WISCONSIN;

EID: 46849086360     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Centers for Disease Control and Prevention. Stroke Facts and Statistics. Available at: http://www.cdc.gov/stroke/stroke_facts.htm. Accessed May 23, 2008.
2. Great Lakes Regional Stroke Network. Fact Sheet: Stroke in Wisconsin. Available at: http://www.uic.edu/depts/glstrk-net/glrsn/facts.html. Accessed May 23, 2008.
3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
4. Hess DC, Wang S, Hamilton W, et al. REACH: clinical feasibility of a rural telestroke network. Stroke. 2005;36:2018-2020.
5. Reed SD, Cramer SC, Blough DK, et al. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001;32:1832-1840.
6. Edwards LL. Using tPA for acute stroke in a rural setting. Neurology. 2007;68:292-294.
7. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol. 2001;58:2009-2013.
8. Wang DZ, Rose JA, Honings DS, et al. Treating acute stroke patients with intravenous tPA. the OSF stroke network experience. Stroke. 2000;31:77-81.
9. American Stroke Association. NIH Stroke Scale Training Online. Available at: http://www.strokeassociation.org/presenter.jhtml?identifier=3023009. Accessed May 23, 2008.
10. Koennecke HC, Roland N, Leistner S, Marx P. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke. 2001:1074-1078.
11. Audebert HJ, Kukla C, Clarmann von Claranau S, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke. 2005:287-291.